Maternal Circulating sFlt-1:PlGF Ratio and Stillbirth

Importance: Stillbirth remains a major global health challenge, particularly in low- and middle-income countries. Angiogenic imbalance, characterized by elevated soluble fms-like tyrosine kinase-1 (sFlt-1) and reduced placental growth factor (PlGF), is implicated in placental dysfunction, yet few studies have examined the association between the sFlt-1:PlGF ratio and stillbirth. Objective: To investigate the association between maternal circulating sFlt-1:PlGF ratio, using clinically relevant cutoffs, and risk of stillbirth. Design, Setting, and Participants: This case-control study included participants from 2 health clinics operated by the Dhaka Community Hospital Trust in rural Bangladesh. Pregnant women aged 18 years or older with ultrasonography-confirmed singleton pregnancies were enrolled before or at 16 weeks' gestation between March 1, 2008, and July 30, 2011. Those delivering stillborn infants (cases) were matched 1:2 with participants in the same cohort who delivered full-term live-born infants (controls). Data were analyzed between September 1, 2025, and January 1, 2026. Exposure: Maternal serum sFlt-1:PlGF ratio. Main Outcomes and Measures: The main outcome was stillbirth, defined as fetal death at 28 weeks' gestation or more. The association between sFlt-1:PlGF ratio cutoffs of greater than 38 and greater than 85 and stillbirth were estimated using Firth penalized logistic regression, with models adjusted using a propensity score incorporating maternal factors. Results: The analytic sample included 125 participants (mean [SD] age, 22.3 [3.8] years), of whom 39 were included in the stillbirth group and 86 in the live birth control group. After adjusting for propensity score, an sFlt-1:PlGF ratio greater than 38 was significantly associated with an increased odds of stillbirth (odds ratio [OR], 13.44; 95% CI, 2.03-88.89). Similar results were observed using the cutoff of 85 (OR, 12.95; 95% CI, 1.57-106.64). Elevated sFlt-1:PlGF ratios showed high positive predictive value for stillbirth at the cutoff of 38 (88.9%; 95% CI, 51.8%-99.7%) and 85 (85.7%; 95% CI, 42.1%-99.6%). Negative predictive values were moderate at 73.3% (95% CI, 64.3%-81.1%) and 72.0% (95% CI, 63.0%-79.9%), respectively, indicating that low ratios had a limited ability to rule out stillbirth. Conclusions and Relevance: This case-control study found that a high sFlt-1:PlGF ratio using clinically relevant thresholds was associated with stillbirth and corresponded to an estimated 13-fold increased risk. These findings suggest that angiogenic imbalance may contribute to stillbirth and highlight the potential utility of angiogenic markers as indicators of pregnancy complications in low-resource settings.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2026-04-17
DOI
https://doi.org/10.1001/jamanetworkopen.2026.7652
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Maternal Circulating sFlt-1:PlGF Ratio and Stillbirth

Mi‐Sun Lee, Ki-Do Eum, David. C. Christiani
JAMA Network Open
Pregnancy and preeclampsia studies
article

Maternal Circulating sFlt-1:PlGF Ratio and Stillbirth

Mi‐Sun Lee, Ki-Do Eum, David. C. Christiani
article en

Abstract

Importance: Stillbirth remains a major global health challenge, particularly in low- and middle-income countries. Angiogenic imbalance, characterized by elevated soluble fms-like tyrosine kinase-1 (sFlt-1) and reduced placental growth factor (PlGF), is implicated in placental dysfunction, yet few studies have examined the association between the sFlt-1:PlGF ratio and stillbirth. Objective: To investigate the association between maternal circulating sFlt-1:PlGF ratio, using clinically relevant cutoffs, and risk of stillbirth. Design, Setting, and Participants: This case-control study included participants from 2 health clinics operated by the Dhaka Community Hospital Trust in rural Bangladesh. Pregnant women aged 18 years or older with ultrasonography-confirmed singleton pregnancies were enrolled before or at 16 weeks' gestation between March 1, 2008, and July 30, 2011. Those delivering stillborn infants (cases) were matched 1:2 with participants in the same cohort who delivered full-term live-born infants (controls). Data were analyzed between September 1, 2025, and January 1, 2026. Exposure: Maternal serum sFlt-1:PlGF ratio. Main Outcomes and Measures: The main outcome was stillbirth, defined as fetal death at 28 weeks' gestation or more. The association between sFlt-1:PlGF ratio cutoffs of greater than 38 and greater than 85 and stillbirth were estimated using Firth penalized logistic regression, with models adjusted using a propensity score incorporating maternal factors. Results: The analytic sample included 125 participants (mean [SD] age, 22.3 [3.8] years), of whom 39 were included in the stillbirth group and 86 in the live birth control group. After adjusting for propensity score, an sFlt-1:PlGF ratio greater than 38 was significantly associated with an increased odds of stillbirth (odds ratio [OR], 13.44; 95% CI, 2.03-88.89). Similar results were observed using the cutoff of 85 (OR, 12.95; 95% CI, 1.57-106.64). Elevated sFlt-1:PlGF ratios showed high positive predictive value for stillbirth at the cutoff of 38 (88.9%; 95% CI, 51.8%-99.7%) and 85 (85.7%; 95% CI, 42.1%-99.6%). Negative predictive values were moderate at 73.3% (95% CI, 64.3%-81.1%) and 72.0% (95% CI, 63.0%-79.9%), respectively, indicating that low ratios had a limited ability to rule out stillbirth. Conclusions and Relevance: This case-control study found that a high sFlt-1:PlGF ratio using clinically relevant thresholds was associated with stillbirth and corresponded to an estimated 13-fold increased risk. These findings suggest that angiogenic imbalance may contribute to stillbirth and highlight the potential utility of angiogenic markers as indicators of pregnancy complications in low-resource settings.

JAMA Network OpenVol. 9(4)
Brigham and Women's Hospital (US), Harvard University (US), Massachusetts General Hospital (US)
No poverty
Openalex Percentile: Top 14%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.